This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cellartgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Su Ran Kim: Innovator in Organoid Technology
Introduction
Su Ran Kim is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of organoid technology, particularly through her innovative patent that focuses on organ extracellular matrix-derived scaffolds. Her work aims to enhance the culture and transplantation of organoids, which are miniature, simplified versions of organs.
Latest Patents
Su Ran Kim holds a patent for an "Organ extracellular matrix-derived scaffold for culture and transplantation of organoid and method of preparing the same." This patent describes a scaffold composition that includes an organ extracellular matrix, with the organ selected from the intestine, stomach, liver, and lung. The preparation of this scaffold involves decellularizing isolated organ tissue to create a decellularized organ tissue, drying it to form an organ extracellular matrix, and gelating the dried matrix. The process of culturing an organoid is facilitated by using this scaffold composition.
Career Highlights
Su Ran Kim is currently associated with Cellartgen Inc., where she continues to advance her research in organoid technology. Her work is pivotal in the development of new methods for organ transplantation and regenerative medicine. With her innovative approach, she is contributing to the future of medical science.
Collaborations
Su Ran Kim collaborates with notable colleagues, including Soo Han Bae and Jin Gu Lee. These partnerships enhance her research efforts and contribute to the advancement of organoid technology.
Conclusion
Su Ran Kim is a trailblazer in the field of organoid technology, with her innovative patent and ongoing research at Cellartgen Inc. Her contributions are shaping the future of organ transplantation and regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile